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CASE REPORT
PULMONARY ARTERY CATHETER
COMPLICATIONS: REPORT ON A CASE OF A KNOT
ACCIDENT AND LITERATURE REVIEW
Marcelo Cruz Lopes, Roberto de Cleva, Bruno Zilberstein and Joaquim José
Gama-Rodrigues
LOPES MC et al. - Pulmonary artery catheter complications: report on a case of a knot accident and literature review. Rev.
Hosp. Clín. Fac. Med. S. Paulo 59(2):77-85, 2004.
A particular event concerning a Swan-Ganz catheter complication is reported.
A 41-year-old woman was admitted at the emergency room of our hospital with massive gastrointestinal bleeding. A
total gastrectomy was performed.
During the postoperative period in the intensive care unit , the patient maintained hemodynamic instability. Invasive
hemodynamic monitoring with a pulmonary artery catheter was then indicated. During the maneuvers to insert the catheter,
a true knot formation was identified at the level of the superior vena cava.
Several maneuvers by radiological endovascular invasive techniques allowed removal of the catheter. The authors
describe the details of this procedure and provide comments regarding the various techniques that were employed in
overcoming this event.
A comprehensive review of evidence regarding the benefits and risks of pulmonary artery catheterization was performed.
The consensus statement regarding the indications, utilization, and management of the pulmonary artery catheterization
that were issued by a consensus conference held in 1996 are also discussed in detail.
KEY WORDS: Intensive care unity. Swan-Ganz catheterization. Invasive hemodynamic monitoring. Pulmonary
artery catheter complications. Pulmonary artery catheter knot formation.
Since it was introduced in 1970,
the Swan-Ganz catheter has permitted
a better understanding of the physi-
opathologic changes in shock states1.
At first, the Swan-Ganz catheter
was employed only in patients with
myocardial infarction. In 1972, the in-
troduction of the thermodilution tech-
nique made bedside measurement of
cardiac output possible and therapeu-
tic guidelines based on hemodynamic
data a reality.
Nevertheless, after many years of
continuous use in critically ill patients,
there is no scientific evidence that the
use of Swan-Ganz catheters improves
patient prognosis2.
Pulmonary artery catheterization
(PAC) has been accepted worldwide
for treating critical patients with shock
states. It produces precise measure-
ments under some technical limita-
tions, makes the diagnosis easier, pro-
vides a better evaluation of illness
grade, and reduces the doubts of the
intensivist.
Unfortunately, several types of
complications can occur following in-
vasive hemodynamic monitoring.
The aim of this study is to report a
case of technical complication with the
use of PAC and to make a critical re-
appraisal of complications and ben-
efits of its utilization in clinical prac-
tice.
REPORT OF THE CASE
A 41-year-old female patient was
admitted at the emergency room of our
hospital with hematemesis. The patient
presented a 15 kg weight loss in the
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last 3 months, epigastric pain, and
heartburn.
Endoscopic evaluation showed a
giant gastric ulcer, 6 cm wide, in the
lesser curvature and gastric stasis.
The patient presented a new
hemorrhage during the diagnostic in-
vestigation, and then she was referred
to the intensive care unit (ICU).
In the ICU, she underwent me-
chanical ventilation due to respiratory
failure and hemodynamic instability.
After aggressive resuscitation with
blood and crystalloids, a laparotomy
was performed. A perforated gastric ul-
cer was found close to the pancreas
and gallbladder, and a total gastrec-
tomy, splenectomy, partial pancreate-
ctomy, and cholecystectomy with
Roux-en-Y reconstruction was per-
formed.
The pathologic examination
showed a peptic ulcer with no signs of
malignancy, and the tests for cytome-
galovirus (CMV), human immunode-
ficiency virus (HIV), and lymphoma
were negative.
In the ICU, the patient maintained
hemodynamic instability, and invasive
monitoring using PAC was indicated.
After puncture of the right internal
jugular vein, a Swan-Ganz catheter 93
A-131H-7F (Baxter Healthcare Corpo-
ration) was placed.
During the progression of the cath-
eter, controlled by the pressure curves,
it was impossible to pull it back. The
procedure was stopped and a radio-
logical examination was performed. A
knot formation was detected.
After clinical stabilization, the pa-
tient underwent a cavography by punc-
ture in the femoral vein. A basket cath-
eter was introduced by the Seldinger
technique under fluoroscopic control.
After several unsuccessful attempts
to untie the catheter, the knot was
pulled tight against an 8F sheath to tie
the knot firmly to reduce its diameter.
Then the catheter was pulled back to
maintain the knot close to the cervi-
cal skin and was fixed so that it could
be removed surgically.
Coagulopathy associated with sep-
sis made a cervical approach unsafe,
and the patient underwent an
inguinotomy with dissection of the
right saphenous vein and introduction
of a basket catheter by the Seldinger
technique. The catheter was advanced
to the superior vena cava under
fluoroscopic control.
The knot was attached to the bas-
ket, and then the Swan-Ganz catheter
was severed close to the cervical skin.
The catheter was pulled back to the
saphenous vein and removed through
the inguinal incision.
Independent of the complication
reported, the patient developed a mul-
tiple-organ dysfunction due to septic
shock as well as enteric fistulae with
dehiscence of the abdominal incision,
and she died on the 42th postoperative
day.
DISCUSSION
Complications from PAC may be
classified into 2 main categories: tech-
nical problems and misinterpretation
of data.
The technical complications can
be divided in 3 groups: 1) complica-
tions of establishing central venous
access, 2) complications of the cath-
eterization procedure, and 3) compli-
cations of the catheter residence.
Patients who are monitored by
PAC have high mortality rates, but in
few cases is it possible to attribute
their deaths specifically to PAC and
not the underlying illness. The mortal-
ity rate associated with PAC is 0.02%
to 1.5%2,3.
An estimated 2 million catheters
are sold annually in the Unites States,
and considering the mortality rate dis-
cussed above, an estimated 20,000
deaths per year are associated with
these diagnostic procedures2,3,4.
The complications include:
1) Complications of establishing
central venous access: These in-
clude unintentional puncture of
nearby arteries such the carotid or
subclavian artery, bleeding, pneu-
mothorax, nerve lesions, and air
embolism5-10.
2) Complications of catheterization
procedure: Dysrhythmias are the
primary complication of the cath-
eterization procedure. Minor dys-
rhythmias such as premature ven-
tricular and atrial contractions oc-
cur commonly with the catheter in-
sertion (70% of the pulmonary ar-
tery catheter insertions) but usually
resolve spontaneously after the
catheter is advanced or withdrawn
through the right ventricle. Ven-
tricular tachycardia or fibrillation
occurs occasionally (in 0.3% of
cases) and cardioversion can usu-
ally be achieved with antiarrhyth-
mic drugs or electrical defibrilla-
tion. Catheter introduction can
produce right bundle-branch block
and, in patients with previous left
bundle-branch block, can induce a
complete heart block. In these pa-
tients, a PAC with a pacemaker line
should be utilized. The most seri-
ous adverse effect of the catheteri-
zation procedure is the pulmonary
artery lesion. This complication
occurs in 0.1% to 1.5% of the cases
and is associated with a high mor-
tality rate (53%) influenced by fac-
tors such age, coagulopathy, pul-
monary hypertension, and hepari-
nization11-25.
3) Complications due to catheter
residence: these include venous
thrombosis thrombophlebitis, pul-
monary embolism and infarction,
cardiac mural thrombi, valvular in-
jury, infection, and pulmonary ar-
tery rupture. Sepsis is a potential
complication of pulmonary artery
catheter residence, but its exact in-
cidence is uncertain. Cultures from
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pulmonary artery catheters are of-
ten positive, but it is unclear
whether these represent contamina-
tion, colonization from another
source, or the primary nidus of in-
fection. The infection rates re-
ported in the literature vary consid-
erably—17% for puncture-site in-
fection, 0.7% to 11.4% for cath-
eter-related sepsis, and 1.4% to
34.8% for positive cultures of pul-
monary artery catheter tips26-29.
Although uncommon, intracardiac
knotting of catheter represents an im-
portant complication associated with
pulmonary artery catheter insertion30-37.
The knot or looping formation oc-
curs during an attempt to direct the
catheter to pulmonary wedge position.
Looping and kinking, the precursors of
knotting occur when an excessive
length of catheter has been inserted. In
such an event, the catheter should be
carefully withdrawn to the 30 cm mark
and re-advanced, avoiding careless
maneuvers. Partial loops with large di-
ameters can be formed in the right
atrium or ventricle and must be imme-
diately recognized by the catheter
length marks. At this point, the cath-
eter must be gently withdrawn to the
right atrium before a new attempt to
direct it to the pulmonary artery is
made. If resistance is found during
these maneuvers, the procedure must
be stopped, and an X-ray examination
must be obtained to diagnose a loop-
ing or knotting formation.
Another recommendation is to par-
tially inflate the pulmonary artery
catheter balloon when it is located in
the vena cava. Only after it reaches the
right ventricle it should be completely
inflated. This maneuver can facilitate
the progression of the pulmonary ar-
tery catheter tip to the pulmonary ar-
tery without producing cardiac valve
lesions and can also reduce the possi-
bility of pulmonary artery catheter
looping.
The manufacturers stress that
kinking and looping occurs when an
excessive length of catheter is in-
serted, and they recommend that no
more than 10 to 15 cm should be in-
serted into the right atrium or ventri-
cle during the attempt to position the
catheter. If the pulmonary artery or
wedge pressure are not obtained, the
pulmonary artery catheter must be
carefully withdrawn to the 30 cm
marking and then reintroduced.
The knot formation is a technical
complication that could be prevented
by a skilled professional team follow-
ing the recommended procedures.
If a knot formation is detected,
there are many technical possibilities
for solving this problem. The best and
the least invasive option is the use of
a 0.038-inch movable core-guided
wire through the lumen of the catheter
to untie the knot under fluoroscopic
control. Fluoroscopic control is neces-
sary because of the theoretical hazard
of perforating the catheter, blood ves-
sels, or cardiac chambers. If the knot
is not too tight, this technique should
not introduce an extra hazard to the
patient.
Failure to unknot the catheter oc-
curs when the knot is not loose enough
and/or is located a long distance away
from the tip of the catheter. When this
procedure is unsuccessful, 2 technical
possibilities of combined radiological
and surgical interventions can be em-
ployed.
After local anesthesia at the ven-
otomy site, the flexible sheath is re-
moved and the end of the external por-
tion of the catheter is cut and occluded
by a hemostat. The catheter is thor-
oughly cleansed with antiseptic solu-
tions, the hemostat is momentarily re-
leased, and a 8F venous sheath is in-
troduced over the end of the catheter
and advanced until the tip is in the su-
perior vena cava. Under fluoroscopy
control, the knot is pulled tight against
the sheath to reduce its diameter, al-
most to the caliber of the sheath. The
catheter is then withdrawn with the
sheath to the internal jugular vein and
removed surgically by a venous cut
down.
The traction and removal of the
catheter through the puncture site can
also be done, and this procedure has
already been described. If an internal
jugular vein access was made, the
catheter could be withdrawn through
the puncture site, which is then com-
pressed for 5 minutes for hemostasis.
Nevertheless, this is not considered a
safe procedure because a 7F catheter
has a knot of no less than 0.65 cm,
which could cause vein laceration and
bleeding.
Finally, surgical access to the vein,
withdrawal of the catheter, and suture
of the defect on the vein wall is the
safer procedure.
Another technical possibility is sur-
gical access through the saphenous vein
at the groin. A stone-retriever basket or
a pig-tail catheter is inserted by
fluoroscopic control to snare the distal
end of the pulmonary artery catheter
and direct it to the inferior vena cava.
Afterwards, a loop-snare catheter is used
to attach it firmly at its balloon site.
Figure 1 - Diagram showing the venous sheath
(VS) introduced into the internal jugular vein
(IJV) to tighten the knot in the right atrium
(RA). RV = right ventricle; PA = pulmonary
artery.
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By exerting simultaneous forceful
pulling from both ends of the catheter,
maximum tightening of the knot is
achieved. The proximal exposed end
of the catheter is thoroughly cleansed
with sterile saline, and the knotted por-
tion of the catheter is withdrawn
through saphenous vein.
This is a safe procedure, but it re-
sults in the introduction into the blood
stream of the non-sterile proximal end
of the catheter and posterior ligature
of the saphenous vein. It was the pro-
cedure of choice in the reported case.
Complications caused by misinter-
pretations
The most hazardous complication
of the use of PAC is the uncorrected
collected hemodynamic data, leading
to inappropriate therapeutic strategies.
The accuracy of the wedge pres-
sure measurement is estimated at 85%.
The measurements are exposed to a
number of technical issues and the
intensivist should have a critical ap-
praisal of the data obtained. The
wedge pressure reflects the filling pres-
sure of the left ventricle (when it has
normal or constant compliance) and
helps decisively with fluid manage-
ment of critically ill patients. Another
common problem is the positioning of
the pulmonary artery catheter out of
the III West zone where the wedge
pressure is greater than alveolar pres-
sure. Therefore, the blood flow in this
area is continuous and less influenced
by mechanical ventilation and posi-
tive end-expiratory pressure (PEEP).
This is a functional and not an ana-
tomical concept, because low flow
states, bronchospasm, or PEEP altera-
tions can induce a functional change
from the III West zone to the II zone,
(where the alveolar pressure is greater
than the wedge pressure), or to the I
zone (where the alveolar pressure is
greater than all)38-41.
Other sources of errors include a
catheter introduced too far, a balloon
excessively inflated, incorrect build-
ing of the pressurization system and
lines of saline infusion, and incorrect
calibration.
Studies both in the United States
and in Europe among ICU personnel
have revealed a lack of familiarity with
hemodynamic theory and practice
among of the staff involved with PAC
insertion and maintenance. Only 47%
of the physicians identify a wedge
pressure curve in a clear monitoring
registry, and fewer than 41% could
make a correct interpretation of the
data collected42.
In another study in France, Bel-
gium, and Switzerland, 54% of the
intensivists did not correctly interpret
the information obtained from the
wedge pressure measurement.
Over the past decade, there have
been vigorous debates concerning the
indications and clinical utility of PAC,
Figure 2 - The distal end of the catheter into the superior vena cava after tightening the knot.
Figure 3 - The distal end of the catheter securely snared at the balloon site and withdrawing the
knotted portion of the catheter through the saphenous vein.
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considering the costs and complica-
tions of the procedure43.
An important consequence to the
physician in critical care practice is
the necessity to consider pathophysi-
ologic concepts in the management
plan. Pulmonary artery catheterization
allows the physician to selectively al-
ter the preload or afterload, to con-
struct a Starling curve, and to estimate
cardiac performance under varying
physiological or pharmacological
conditions. In addition, the ability of
PAC to determine pressure gradients
across the pulmonary circulation has
enabled physicians to differentiate
cardiogenic from non-cardiogenic pul-
monary edema. Furthermore, based on
the assessment of the cardiac output
and oxygen delivery, the pulmonary
artery catheter is used to guide the ap-
plication of fluid and titration of va-
soactive drugs to treat shock states
based on physiological criteria44.
The ideal method would be a sys-
tem that provides hemodynamic infor-
mation at the bedside and that deter-
mines beneficial therapeutic changes
in the patients, and that also is easily
operated, produces data that is easily
interpreted, and has a low risk of com-
plications.
Alternatives choices to PAC are the
central venous pressure (CVP), trans-
esophageal echocardiography, thoracic
bioimpedance, gastrointestinal tonom-
etry, and serum lactate.
The prospective assessment of the
benefits of PAC has been hampered by
the lack of clinically prospective,
randomized multicenter studies. This
is a consequence of the prevailing
faith in the merits of the PAC and the
perceived ethical dilemma of ran-
domly “denying” patients access to
PAC.
We reviewed studies with surgical
patients in which the pulmonary artery
catheter was inserted, and the
hemodynamic data was utilized to
change therapeutic approach. Prospec-
tive and randomized studies have been
conducted by several authors to inves-
tigate the results of goal-oriented
hemodynamic therapy with PAC.
Supranormal values of oxygen deliv-
ery index (D02I), oxygen consumption
index (V02I), and cardiac index (CI) in
critically ill postoperative patients
were compared to those with normal
physiological parameters for these vari-
ables45-56.
The therapeutic goals were: DO2I
>600 mL/min/m2 (supranormal) or 450
mL/min/m2 (normal), VO2I >170mL/
min/m2 (supranormal) or 150 mL/min/
m2 (normal), CI >4.5L/min/m2
(supranormal) or CI 2.8-3.8 L/min/m2
(normal), systolic arterial pressure
>120 mm Hg, pulse <110 bpm, Hb >10
g%, CVP 8-12 mmHg, and diuresis of
30-50 mL/kg/h. The analysis of these
studies shows conflicting results.
Gattinoni et al. (1995) performed a
multicenter, prospective, randomized
controlled trial with 762 patients in 56
ICUs to investigate the effect of
supranormal CI (CI >4.5 L/min/m2)
versus a normal CI (2.5-3.5 L/min/m2)
control group. In this trial, no differ-
ence was found in mortality or organ
dysfunction between the treatment and
the control group by the end of the 5-
day study period46.
Boyd et al. (1993) randomized 107
high-risk surgical patients to receive
either preoperative goal-oriented
therapy for supranormal (protocol
group) or normal values, finding a re-
duction in mortality in the protocol
group47.
Bishop et al. (1995) studied 115
trauma patients in a prospective
randomized trial of resuscitation to
supranormal endpoints of CI, DO2I, and
V02I versus resuscitation to normal
hemodynamic endpoints in patients
monitored with PAC or CVP. The pro-
tocol group had lower mortality and
organ dysfunction per patient48.
Flemming et al. (1992) reported
similar results in a study with 67
trauma patients prospectively
analyzed with the same methodology.
The authors found a trend of lower
mortality (not statistically significant)
and a significant reduction in the or-
gan dysfunction indices in the proto-
col group49.
Yu et al. (1993) prospectively stud-
ied 89 surgical patients with the diag-
nosis of adult respiratory distress syn-
drome (ARDS), sepsis, septic shock
randomized to supranormal or normal
D02I, finding no difference between the
groups in the rates of myocardial inf-
arction, ARDS, renal dysfunction, he-
patic dysfunction, intravascular dis-
seminated coagulopathy (IVDC), ICU
length of stay, hospital length of stay,
and costs50.
Hayes et al. (1994) performed a
prospective, randomized trial of 109
patients admitted to an ICU
postoperatively. Protocol patients were
treated to achieve supranormal values
of CI, D02I, and V02I, whereas the con-
trol patients were given inotropes only
if CI was <2.8 L/min/m2 after fluid re-
suscitation. This study was terminated
before sufficient size of statistical
power was achieved, because in-hos-
pital mortality for the protocol group
was higher due to multiple organ dys-
functions. The median of the maximal
dose of norepinephrine given was
higher in the protocol group51.
Isaacson et al. (1990) performed a
prospective, randomized, controlled
trial of preoperative PAC versus CVP
on 102 patients who underwent elec-
tive abdominal aortic reconstructive
surgery after appropriate preoperative
cardiac investigation. No statistical dif-
ference was found between the PAC
and CVP groups with regard to post-
operative morbidity, duration of ICU
stay, or total number of postoperative
hospital days52.
Critical appraisal of the literature
did not demonstrate conclusive find-
ings about the use of PAC in surgical
patients. The American Society of
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Anesthesiologists has performed a
comprehensive review of evidence re-
garding the benefits, risks, and costs of
PAC, which was published as Practice
Guidelines for Pulmonary Artery Cath-
eterization (American Society of
Anesthesiologists Task Force on Pul-
monary Catheterization)4.
In this extensive review, a total of
860 clinical trials, controlled observa-
tional studies, uncontrolled case series
reports, and individual case reports
were reviewed (studies in which the
clinical outcome of the patients was
not mentioned were excluded). The
task force did not directly examine the
accuracy of PAC monitoring, the value
of PAC data as predictor of morbidity
and mortality, or evidence of the effec-
tiveness of treatment for PAC-detect-
able conditions. Issues related to the
performance of PAC, such as rates of
utilization and practitioner skill, re-
source constraints imposed by the
staff, and equipment availability were
not a specific focus of the literature re-
view.
Considerable discussion and de-
bate about the benefits and impact of
PAC monitoring on the treatment suc-
cess, increasing survival rates, and
morbidity reduction remains.
In 1996, the Pulmonary Artery
Catheter Consensus Conference3 was
organized as an aid to clinicians to re-
view the state of knowledge concern-
ing PAC in specific patient
populations, to define specific critical
unanswered questions, and make rec-
ommendations for clinical practice,
and to provide guidance for future
clinical and epidemiological research
in this area.
The Conference participants uti-
lized a methodology based on that de-
scribed by Sackett. To better serve the
needs of the Consensus Conference
and more precisely grade the levels of
evidence used to support responses to
the questions posed, Sackett’s original
3 grades of A, B, and C were expanded
to A, B, C, D, and E3,57. The grade
given for the response to a question
simply reflects the level of evidence
currently available to answer the ques-
tion. The grade given to an answer is
extremely important since it differen-
tiates between an answer that may be
based on well-designed, randomized,
controlled trials, and an answer based
on expert opinion. The answer “uncer-
tain” means that the available evi-
dence is conflicting or that Consensus
Conference participants perceived sig-
nificant methodological errors in the
investigation, making interpretation
difficult or impossible.
The traumatically injured patient
represents a challenge to the
intensivist, and PAC monitoring for
better diagnostic or therapeutic man-
agement is of great interest. In the
Consensus Conference review, no con-
trolled trials that met their inclusion
criteria proved the benefit of PAC in
traumatically injured patients. Expert
opinion suggests that in the multiple
traumatized patient, PAC may alter di-
agnosis and improve outcome when
the therapeutic objectives are as fol-
lows: 1) to ascertain the status of un-
derlying cardiovascular performance;
2) to direct therapy when noninvasive
monitoring is inadequate or mislead-
ing; 3) to assess response to resuscita-
tion; 4) to potentially decrease sec-
ondary injury when severe close head
or spinal cord injuries are components
of multisystem trauma; 5) to augment
clinical decision making when major
trauma is complicated by ARDS, pro-
gressive oliguria, myocardial injury,
congestive heart failure, or major ther-
mal injury; or 6) to establish futility
of care.
In the sepsis/septic shock states,
the improvement of clinical outcomes
by PAC-guided management was con-
sidered to be an uncertain possibility.
Mimoz et al. (1994) suggested that
outcomes may be better in patients
with septic shock who are unrespon-
sive to fluid resuscitation and
vasoconstrictors if the information
from the PAC prompts a change in the
therapy58.
Reynolds et al. (1988) demon-
strated an improved outcome in pa-
tients with septic shock after physi-
cians formally trained in critical care
medicine began staffing a medical ICU
in a university hospital. The Consen-
sus Committee recommended PAC uti-
lization in patients with septic shock
who do not respond to initial aggres-
sive fluid resuscitation and low doses
of inotropic/vasoconstrictor therapy59.
Supranormal oxygen delivery to
patients with systemic inflammatory
response syndrome—organ-related
dysfunction from septic shock, trauma,
or postoperative complications—is
not recommended either for lowering
mortality rates, decreasing the inci-
dence of organ dysfunction, or improv-
ing function of compromised organs.
The discussion about the risks and
benefits of PAC utilization still occurs
after 30 years of clinical practice. The
following recommendations reflect the
collective opinion of the Consensus
Conference participants:
• There is no basis for an FDA mora-
torium of PAC use at this time. A
pulmonary artery catheter is con-
sidered a class II device—one that
requires general and specific con-
trol to reasonably assure safety and
effectiveness. A reasonable assur-
ance of safety occurs when the
probable benefits to health from
the use of the device outweighs
any probable risks. Effectiveness is
assured when, in a significant pro-
portion of the target population,
the use of the device as intended
provides clinically important re-
sults.
• Deaths and serious injuries caused
by PAC use are extremely rare. The
indications for use identified by
pulmonary artery catheter manu-
facturers are measurements such as
83
REV. HOSP. CLÍN. FAC. MED. S. PAULO 59(2):77-85, 2004 Pulmonary artery catheter complications
Lopes MC et al.
hemodynamic pressures, thermodi-
lution cardiac output, continuous
cardiac output, mixed venous oxy-
gen saturation, and blood sam-
pling; intended uses have not in-
cluded claims of clinical benefit.
Evidence suggests that PAC-de-
rived data that are not obtainable
clinically and that help in guiding
therapy adjustments may lead to a
more appropriate approach.
• Clinicians should continue to care-
fully weigh the risks and benefits
of PAC, and patients or guardians
should be fully informed before
use.
• Criteria for the appropriate use of
the PAC in specific clinical situa-
tions should be developed.
• Clinician knowledge about use of
the PAC and its complications
should be improved.
• Current training, credentialing, and
continuing quality improvement
issues related to the PAC should be
re-evaluated.
• The indications and contrain-
dications for PAC use where clini-
cal equipoise is lacking should be
well determined.
• Clinical trials for indications where
clinical equipoise exists should be
performed.
RESUMO
LOPES MC e col. - Complicações do
cateter de artéria pulmonar: relato
de caso de formação de nó verda-
deiro revisão da literatura. Rev.
Hosp. Clín. Fac. Med. S. Paulo
59(2):77-85, 2004.
É relatada uma complicação infre-
qüente , associada ao uso do Cateter
de Artéria Pulmonar.
Uma paciente de 41 anos foi admi-
tida no Pronto Socorro do nosso hos-
pital com hemorragia digestiva alta
grave. A doente foi submetida à gas-
trectomia total.
Na Unidade de Terapia Intensiva,
evoluiu com instabilidade hemodi-
nâmica, sendo indicada a monitorização
hemodinâmica invasiva com cateter de
artéria pulmonar. Durante as manobras
para o correto posicionamento do cate-
ter na artéria pulmonar, foi diagnostica-
do formação de nó verdadeiro, ao ní-
vel da veia cava superior.
Os autores discutem as várias op-
ções técnicas empregadas para a reso-
lução desta complicação, através do
emprego da radiologia intervencio-
nista endovascular.
Extensa revisão da literatura procu-
rando discutir os benefícios e riscos
envolvidos na monitorização hemo-
dinâmica invasiva com o cateter de ar-
téria pulmonar, no período peropera-
tório, foi realizada. Assim como as ori-
entações práticas emitidas pela Confe-
rência de Consenso sobre o cateter de
artéria pulmonar, realizada nos EUA em
1996, são discutidas com profundida-
de.
UNITERMOS: Unidade de Terapia
Intensiva. Cateter de Artéria Pulmo-
nar. Monitorização hemodinâmica
invasiva. Complicações do cateter de
artéria pulmonar. Formação de nó
no cateter de artéria pulmonar.
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